SANDELL SCOTT D purchased 214.3% of their position (4.40M shares) of REGULUS THERAPEUTICS INC. on the open market
Open‑market purchase worth $2.74M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/7/2020ACC: 0001209191-20-061973
10% Owner
Since May 2019
+9.90M
Net shares
Net buyer
$2.74M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
9.90M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+4.40M
Price / share
$0.62
Trade value
$2.74M
% of position
214.3%
12/4/2020
2.05M→6.45M
Total
Net shares
+4.40M
Net value
$2.74M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/4/2020 | P · Purchase | +4.40M | $0.62 | $2.74M | 214.3% | 2.05M | 6.45M |
| Total | +4.40M | $2.74M | ||||||
Derivative Transactions2
Common Stock Purchase Warrant (right to buy)
Indirect
Converts to
Common Stock
5.24M shares
Shares
+5.24M
Strike price
0.7464
Held after
5.24M
Exercisable
—
12/4/2020
Class A-3 Convertible Preferred Stock
Indirect
Converts to
Common Stock
2.59M shares
Shares
+258.71K
Strike price
Held after
258.71K
Exercisable
—
12/4/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Purchase Warrant (right to buy) Indirect | Common Stock5.24M shares | 12/4/2020 | P · Purchase | +5.24M | 0.7464 | — | 5.24M |
| Class A-3 Convertible Preferred Stock Indirect | Common Stock2.59M shares | 12/4/2020 | P · Purchase | +258.71K | — | 258.71K |